Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Medicina (Kaunas) ; 60(1)2024 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-38256362

RESUMO

Adenoid cystic carcinoma (ACC) is a rare malignant tumor that mostly occurs in minor glands, especially in the palate. Intraosseous adenoid cystic carcinoma (IACC) is rarer. There is no clear conclusion on the clinical, radiologic and pathological characteristics of IACC because of few reported IACC cases, leading to insufficient understanding of IACC. We reviewed 52 previous reports of primary IACC (PIACC) and analyzed the clinical features of those patients involved, attempting to provide a better understanding of PIACC. Moreover, we present a case of primary PIACC and a case of recurrent IACC (RIACC). The two patients showed similarities in clinical and pathological results, along with slight differences in radiological and immunohistochemical results. The patient of case 1 seemed to display a worse prognosis, which can only be proved after long term follow-up.


Assuntos
Carcinoma Adenoide Cístico , Humanos , Carcinoma Adenoide Cístico/diagnóstico por imagem
3.
Neuropsychologia ; 203: 108969, 2024 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-39122147

RESUMO

Numerous research studies have demonstrated that eye gaze and arrows act as cues that automatically guide spatial attention. However, it remains uncertain whether the attention shifts triggered by these two types of stimuli vary in terms of automatic processing mechanisms. In our current investigation, we employed an equal probability paradigm to explore the likenesses and distinctions in the neural mechanisms of automatic processing for eye gaze and arrows in non-attentive conditions, using visual mismatch negative (vMMN) as an indicator of automatic processing. The sample size comprised 17 participants. The results indicated a significant interaction between time duration, stimulus material, and stimulus type. The findings demonstrated that both eye gaze and arrows were processed automatically, triggering an early vMMN, although with temporal variations. The vMMN for eye gaze occurred between 180 and 220 ms, whereas for arrows it ranged from 235 to 275 ms. Moreover, arrow stimuli produced a more pronounced vMMN amplitude. The earlier vMMN response to eye gaze compared with arrows implies the specificity and precedence of social information processing associated with eye gaze over the processing of nonsocial information with arrows. However, arrow could potentially elicit a stronger vMMN because of their heightened salience compared to the background, and the expansion of attention focusing might amplify the vMMN impact. This study offers insights into the similarities and differences in attention processing of social and non-social information under unattended conditions from the perspective of automatic processing.

4.
Biomed Pharmacother ; 176: 116844, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38823279

RESUMO

In contemporary times, tumors have emerged as the primary cause of mortality in the global population. Ongoing research has shed light on the significance of neurotransmitters in the regulation of tumors. It has been established that neurotransmitters play a pivotal role in tumor cell angiogenesis by triggering the transformation of stromal cells into tumor cells, modulating receptors on tumor stem cells, and even inducing immunosuppression. These actions ultimately foster the proliferation and metastasis of tumor cells. Several major neurotransmitters have been found to exert modulatory effects on tumor cells, including the ability to restrict emergency hematopoiesis and bind to receptors on the postsynaptic membrane, thereby inhibiting malignant progression. The abnormal secretion of neurotransmitters is closely associated with tumor progression, suggesting that focusing on neurotransmitters may yield unexpected breakthroughs in tumor therapy. This article presents an analysis and outlook on the potential of targeting neurotransmitters in tumor therapy.


Assuntos
Progressão da Doença , Neoplasias , Neurotransmissores , Humanos , Neurotransmissores/metabolismo , Neoplasias/patologia , Neoplasias/metabolismo , Animais , Neovascularização Patológica/patologia , Neovascularização Patológica/metabolismo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa